SCHEMBL23778296

SCHEMBL23778296

Cc1ccnc(C2(C#N)CCC(=O)CC2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
UHRF1 Q96T88 1/20 0.34
CCR1 P32246 1/20 0.34
CCR5 P51681 1/20 0.34
CCR8 P51685 1/20 0.34
PIK3CA P42336 2/20 0.34
RAF1 P04049 5/20 0.33
BRAF P15056 5/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13806000 0.88 UHRF1 (0.41) UHRF1CCR1CCR5CCR8PIK3CA
SCHEMBL13805993 0.84 UHRF1 (0.38) UHRF1CCR1CCR5CCR8PIK3CA
SCHEMBL2220946 0.81 SYK (0.38) UHRF1CCR1CCR5CCR8PIK3CA
SCHEMBL6884199 0.79 OPRM1 (0.54) CCR1CCR5CCR8PIK3CAKDM4E
SCHEMBL23778454 0.78 RAB9A (0.37) PDE4APDE4BPDE4CPDE4DCCR1
SCHEMBL142383 0.77 PRKCA (0.43) PDE4APDE4BPDE4CPDE4DCCR1
SCHEMBL6888915 0.76 ADRA1A (0.41) PDE4APDE4BPDE4CPDE4DCCR1
Ethylene SCHEMBL3966670 0.75 PRKCA (0.41) PDE4APDE4BPDE4CPDE4DCCR1
SCHEMBL3973047 0.74 VNN1 (0.33) PDE4APDE4BPDE4CPDE4D
SCHEMBL23798000 0.73 PIK3CA (0.37) CCR1CCR5CCR8PIK3CARAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3526207-B1 HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. HEPTARES THERAPEUTICS LTD (GB) 2021-09-08 EP disclosed